Bio-Techne balance sheet

At the end of fiscal 2026, Bio-Techne had total assets of $2.59bn and shareholders' equity of $2.11bn. It held $265m in cash against $200m of debt: net cash of $64.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bio-Techne: balance sheet, annual
Fiscal year	2010Jun 2010	2011Jun 2011	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Cash and equivalents	94	78	117	164	319	55	64	92	122	101	147	199	173	181	152	162	265
Receivables	31	36	36	38	55	70	93	117	120	137	123	145	195	218	241	207	217
Inventory	14	45	38	35	39	50	57	86	86	91	103	117	141	172	180	189	196
Total current assets	201	230	347	410	469	248	254	348	398	413	521	511	606	621	617	608	744
Goodwill	25	87	86	84	151	391	431	579	598	733	728	843	822	873	973	981	975
Total assets	519	618	719	778	862	1,063	1,130	1,558	1,593	1,884	2,028	2,263	2,295	2,639	2,704	2,558	2,587
Accounts payable	5	5	6	6	10	13	21	17	18	16	23	29	34	26	38	25	27
Deferred revenue (current)	—	—	—	—	0	3	5	6	8	9	13	19	23	23	28	33	36
Total current liabilities	17	18	36	32	26	40	54	136	80	102	107	152	176	129	159	176	164
Short-term debt	—	—	—	—	—	—	—	—	—	13	13	13	13	—	—	—	—
Long-term debt	—	—	—	—	0	73	92	344	339	493	344	329	243	350	319	346	200
Total debt	0	0	0	0	0	73	92	344	339	505	357	341	256	350	638	346	200
Shareholders' equity	502	586	674	738	795	847	879	950	1,079	1,166	1,381	1,563	1,702	1,967	2,069	1,919	2,108
Net debt (negative = net cash)	−94	−78	−117	−164	−319	18	27	252	217	404	210	142	83	169	486	184	−65
Shares outstanding	148m	149m	147m	147m	148m	149m	149m	149m	150m	152m	154m	156m	157m	158m	158m	155m	156m

US$ millions unless shown otherwise. Fiscal quarters.

Bio-Techne: balance sheet, quarterly
Quarter	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025	2026 Q3Mar 2026	2026 Q4Jun 2026
Receivables	224	218	237	207	184	185	215	217
Inventory	185	188	191	189	203	205	201	196
Total current assets	649	635	627	608	610	637	688	744
Goodwill	983	965	969	981	979	981	978	975
Total assets	2,736	2,670	2,644	2,558	2,526	2,523	2,551	2,587
Accounts payable	32	33	32	25	30	26	23	27
Deferred revenue (current)	27	28	32	33	30	31	38	36
Total current liabilities	142	161	169	176	145	140	153	164
Long-term debt	300	300	330	346	300	260	200	200
Total debt	300	300	330	346	300	260	200	200
Shareholders' equity	2,139	2,078	2,018	1,919	1,966	2,011	2,085	2,108
Shares outstanding	159m	158m	157m	155m	156m	156m	157m	156m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SHC vs TECH RGEN vs TECH NEO vs TECH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Bio-Techne's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bio-Techne.